Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Principal Scientist Medicinal Chemistry iMed CVMD Medicinal Chemistry Department AstraZeneca is a global, science- and innovation-driven biopharmaceutical company. We are proud to have a unique workplace culture that inspires innovation and collaboration. Employees are empowered to express diverse views and are valued and rewarded for their ideas and creativity. The Cardiovascular and Metabolic Diseases (CVMD) iMed vision is to push the boundaries of science to deliver life-changing medicines to patients suffering from cardiovascular and metabolic diseases, and our strategy focuses on cardiac regeneration, islet health and diabetic nephropathy. The role This is a senior scientific role within the Medicinal Chemistry department. You will be an authority in medicinal chemistry and will develop and lead the science in this field. You will have a profound impact on multiple projects across the CVMD iMed, in all phases from target selection to drug candidate selection. The role holder will also provide discipline based scientific leadership and represent the department and AstraZeneca at interdisciplinary meetings internally as well as externally. The roleholder will influence the strategy of Medicinal Chemistry as well as the implementation of Disease Area strategies. Key Deliverables: Lead the medicinal chemistry input in projects and in cross functional disease area project team. Responsible together with the Med Chem Leadership Team for clear, compelling scientific strategy in the field of medicinal chemistry Recommend, gain commitment to, initiate, lead and champion new innovations that help the iMed meet its overall objectives Evaluate and manage external collaborations & in-licensing opportunities Demonstrate scientific leadership through high quality publications, conference presentations and by building networks with key opinion leaders and academic groups Show strong leadership capabilities in collaborative working, strategic thinking and in the development of people and organization. Experience Ideally, you should have a Ph. D. degree in a relevant scientific discipline with 10 or more years post-doctoral research experience in medicinal chemistry and drug discovery, preferentially from an industrial setting. You will have the ability to operate effectively in a multidisciplinary matrix research environment, providing leadership and insight in medicinal chemistry. You will be recognised internationally as evidenced by your external disclosures and publication record. This role also demands in-depth collaboration skills. Experience from leading projects or chemistry programs on projects as well as proven knowledge in cardiovascular and metabolic disease area will be seen as advantages. Key qualities: A highly self-motivated, scientifically critical individual capable of receiving and analyzing input from multiple disciplines and deciding on focused course of action Will have a proven strong track record of innovation and milestone delivery in several drug discovery projects. Very good influencing skills in order to build capabilities in medicinal chemistry and implement improvements. Very good knowledge of related disciplines including DMPK, safety, bioscience, IP and pharmaceutical development Very good written and verbal communication skills, including presentations to senior leaders More information If you have any questions about this role, please contact the hiring manager: Malin Lemurell Head of Department CVMD iMed Medicinal Chemistry Phone: +46 31 776 2897 Mobile: +46 73 066 77 81 [email protected] We only accept applications via our web system, please follow link to apply. http://jobs.astrazeneca.com/jobs/details/l1rMOL000001F8-principal-scientistmedicinal-chemistry-imed-cvmd-medicinal-chemistry-department Welcome with your application no later than August 31, 2014.